Morgan Jones is an accomplished professional in business development and corporate strategy, currently serving as Executive Director of Corporate Development at Bristol Myers Squibb since 2025. They have held various roles at Pfizer, including Manager and Senior Manager of Corporate Development, and also served as Director of Corporate Development for Rare Disease. Prior to this, between 2016 and 2018, Morgan worked in healthcare investment banking at Jefferies. They have also held leadership positions at Lexeo Therapeutics and Verve Therapeutics, focusing on business development and corporate strategy. Morgan is pursuing a Bachelor of Science in Mathematics at Penn State University.
This person is not in any teams
This person is not in any offices